Delivery Order SPE2DB22D1002-SPE2DB24FKZG7
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,910.94, is for the delivery of dexamethasone 0.5 mg/5 ml elixir, a medical product used for various medical treatments. The contract has a completion date of March 27, 2025 and is a firm fixed-price delivery order. No set-aside designation was used for this award. AmerisourceBergen holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Dexamethasone 10 mg/mL vials. The fixed-price delivery order, valued at $2,176.66, has a period of performance through January 24, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical for...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,723.10, is a Firm-Fixed-Price Delivery Order for the purchase of 4 mg dexamethasone tablets. The contract has an ultimate completion date of December 11, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,280.12 firm fixed-price delivery order is for the supply of 10 mg/mL vials of the medication dexamethasone. The contract has an ultimate completion date of May 19, 2025 and is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of dexamethasone 0.5 mg/5 ml elixir, a pharmaceutical product. The contract has a ceiling value of $8,299.60 and a performance period ending on April 28, 2025. The contract is a firm fixed-price, non-set-aside delivery order. Amerisourcebergen Drug Corp is the prime contractor and this award is part of a larger...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,732.57 firm fixed price delivery order is for the supply of DEXAMETHASONE 0.5 MG/5 ML ELX 237ML, a medical product used in various treatment applications. The award has a completion date of July 15, 2024 and is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of dexamethasone 20 mg/5 ml vial, a critical pharmaceutical product. The $2,376.00 firm-fixed-price contract has a performance period through September 24, 2024. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor and there is no set-aside designation. This order is likely part of a larger Indefinite Delivery Contract (IDC) between...
- This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is for the supply of DEXAMETHASONE 20 MG/5 ML VIAL 5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $1,095.97 firm fixed-price delivery order has an ultimate completion date of August 29, 2024. Amerisourcebergen is a major supplier of pharmaceutical and medical products to the U.S. government, holding several Indefinite Delivery Contracts (IDCs) with...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of Dexamethasone 20 mg/5 ml vials. The firm-fixed-price contract has a ceiling value of $1,491.26 and an ultimate completion date of August 30, 2024. This contract is not associated with a set-aside program. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this award, which is part of the company's extensive federal contracting activities...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,182.24, is for the delivery of 4,566,189,769 milliliters of dexamethasone 10 mg/mL vials. The contract is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of October 25, 2024. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- SPE2DB22D1002Indefinite Delivery Contract
- SPE2DB22D1002-SPE2DB24FKZG7Delivery Order
This federal contract award is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the supply of Dexamethasone 0.5 mg/5 ml Elixir, a pharmaceutical product, with a ceiling value of $1,792.29 and a period of performance through March 14, 2024. The contract is a firm fixed price arrangement and does not have a set-aside designation. Amerisourcebergen Drug Corp also holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary contract vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This IDC enables Amerisourcebergen to provide a comprehensive range of medications and healthcare materials to military treatment programs and medical facilities worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 3/13/24 |